Research Article

Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways

Table 1

Comparison of baseline data of both groups [, n (%)].

GroupingGenderAverage age (years)NYHA classificationCombined with diabetesCombined with hyperlipidemiaPrimary disease
MaleFemaleIIIIICoronary heart diseaseDilated cardiomyopathyHypertensive heart diseasePulmonary heart disease

Intervention group5633 (58.93)23 (41.07)35 (62.50)21 (37.50)15 (26.79)22 (39.29)21 (37.50)13 (23.21)12 (21.43)10 (17.86)
Control group5530 (54.55)25 (45.45)37 (67.27)18 (32.73)17 (30.71)20 (36.36)20 (36.36)15 (27.27)10 (18.18)10 (18.18)
0.2170.6520.2770.2300.1010.340
0.6410.5160.5990.6320.7510.952